Dr. Martens Share News (DOCS)

LONDON MARKET MIDDAY: Europe rises but FTSE 100 underperforms

(Alliance News) - Stock prices in London were lower at midday on Monday, though European peers were on the rise, following favourable eurozone economic data.

PRESS: Activist investor buys into bootmaker Dr Martens - Sky News

(Alliance News) - Dr Martens PLC shares climbed after Sky News reported Saturday that activist investment manager Sparta Capital Management Ltd has built a stake worth "tens of millions" in the bootmaker.

Bootmaker Dr Martens gains on report of stake building by activist investor

July 31 (Reuters) -

Sparta Capital builds stake in Dr.Martens

(Sharecast News) - Activist investor Sparta Capital has built up a stake in Dr Martens.

Director dealings: Dr Martens chief buys the dip, HICL board member invests

(Sharecast News) - Dr Martens was among those companies on the list of director buys on Monday, after its chief executive officer added more than 300,000 shares to his holding.

IN BRIEF: Dr Martens CEO Kenny Wilson buys GBP400,000 in shares

Dr Martens PLC - Northamptonshire, England-based boot manufacturer - Chief Executive Officer Kenny Wilson buys 309,948 shares at GBP1.29 each, worth GBP399,998, on Friday last week. On Thursday, Dr Martens had provided a trading update, saying sales in the first quarter was in line with its expectations, as Japan led growth in Asia.

LONDON BROKER RATINGS: JPMorgan cuts Spectris; Berenberg likes Victrex

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

FTSE 100 closes lower at the end of best week in three months

Spirax-Sarco gains on UBS upgrade

*

Bank of America Merrill Lynch ups Dr Martens to 'buy'

(Sharecast News) - Dr Martens surged on Friday after Bank of America Merrill Lynch lifted the stock to 'buy', arguing that the iconic bootmaker has an "attractive value proposition".

IN BRIEF: Dr Martens sales up in Japan but Americas need "improvement"

Dr Martens PLC - Northamptonshire-based boot maker - Says "addressing our performance" in the Americas is its "number one priority" for the current financial year, but "meaningful improvement" will take until the second half of the year, which ends March 31, 2024. Dr Martens says trading in the first quarter, which is the smallest period of its financial year, was in line with its expectations. The Europe, Middle East and Africa and Asia-Pacific regions saw "very good growth", with Asian sales driven by Japan. By contrast, Americas revenue was down from a year before, in line with expectations and mostly due to the wholesale business.

Dr Martens sees progress on rectifying US issues, trading in line

(Sharecast News) - UK bootmaker Dr Martens said progress had been made rectifying the US warehousing fiasco that led to a series of profit warnings, and trading since the start of the current financial year had been in line with expectations.

UK dividends calendar - next 7 days

UK shareholder meetings calendar - next 7 days

LONDON BROKER RATINGS: Goldman Sachs cuts Great Portland to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

RBC Capital Markets cuts Dr Martens price target as it lowers estimates

(Sharecast News) - RBC Capital Markets slashed its price target on Dr Martens on Monday to 150p from 180p, keeping the rating at 'sector perform', as it lowered estimates after the bootmaker's results.